Medical Doctor Program year 2025 Reported 2022–2025 Source: CMS Open Payments, 2026 publication

Daniel Nelson

Clinical Cardiac Electrophysiology Appleton, WI Medical Doctor

NPI 1750812491 CMS profile 11425598

5045 W Grande Market Dr, Appleton, WI 54913

Open in the dashboard

General payments

$49,898

283 records reported · program years 2022–2025

Research payments

$0

Paid to them · None reported · program years 2022–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Daniel Nelson of Appleton, WI is reported in the CMS Open Payments database as having received $49,898 across 283 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 76th percentile of Clinical Cardiac Electrophysiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

4 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $12,573 85
2024 General $18,568 126
2023 General $17,774 65
2022 General $984 7

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Daniel Nelson
  • Clinical Cardiac Electrophysiology median
  • Middle half of Clinical Cardiac Electrophysiology
  • National median

In program year 2025, general payments to Daniel Nelson were reported at $12,573. Among 3,064 Clinical Cardiac Electrophysiology profiles paid that year, the median was $2,462 and the middle half received between $733 and $7,710.

Show as a table
Year Daniel Nelson Clinical Cardiac Electrophysiology median Middle half National median
2019 $0 $2,361 $585–$8,260 $163
2020 $0 $993 $247–$4,351 $114
2021 $0 $1,185 $326–$4,739 $132
2022 $984 $2,073 $554–$6,789 $149
2023 $17,774 $2,568 $759–$8,159 $160
2024 $18,568 $2,557 $703–$7,403 $164
2025 $12,573 $2,462 $733–$7,710 $169

Breakdown

Who paid General payments · program years 2022–2025
  1. Abbott Laboratories $17,960 80 payments
  2. Medtronic, Inc. $15,541 112 payments
  3. Boston Scientific Corporation $9,342 37 payments
  4. Medical Device Business Services, Inc. $3,016 27 payments
  5. Biotronik Inc. $1,926 12 payments
  6. Biosense Webster, Inc. $1,732 12 payments
  7. Edwards Lifesciences Corporation $206 1 payment
  8. ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) $97 1 payment
  9. Abiomed $80 1 payment

Every payment, record by record

What the payments were for General payments · program years 2022–2025
  1. Travel and Lodging $21,310 101 payments
  2. Grant $14,583 6 payments
  3. Food and Beverage $13,353 172 payments
  4. Education $652 4 payments
Products named General payments · program years 2022–2025
  1. ENSITE PRECISION $4,910 37 payments
  2. Carto 3 $4,606 37 payments
  3. Micra $3,192 26 payments
  4. General - EP $2,467 8 payments
  5. ENSITE $2,324 19 payments
  6. VersaCross Access Solution Icg $984 7 payments
  7. AGILIS $823 6 payments
  8. VersaCross Access Solution VersaCross Access Solution_ICG $804 4 payments
  9. GALLANT $654 10 payments
  10. AMVIA EDGE $490 1 payment
  11. Other $3,311 28 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 2 drugs

Part D claims

52

Median for Clinical Cardiac Electrophysiology: 1,090

Drug cost

$26,968

Median for Clinical Cardiac Electrophysiology: $354,841

Branded share of claims

42.3%

Median for Clinical Cardiac Electrophysiology: 38.3%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Eliquis Apixaban Brand 22 $26,787
Doxycycline Hyclate Generic 30 $181

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 2,573 Part D prescribers listed as Clinical Cardiac Electrophysiology; they describe a distribution and say nothing about conduct.

Records

283 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Clinical Cardiac Electrophysiology in Wisconsin

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record